Dana-Farber Cancer Care Collaboration Brings New Breast Cancer Research Trial to Eastern Maine Medical Center Patients


(Brewer, Maine) – When Eastern Maine Medical Center entered into its collaboration with the Dana-Farber Cancer Institute in Boston, one of the patient benefits included access to more treatments close to home. That commitment took another step forward recently when Eastern Maine Medical Center became the only site in Maine to offer a clinical trial for women diagnosed with specific kinds of breast cancer who have not yet had surgery.
“We are pleased to be able to offer clinical trials to patients specifically because of our participation in the Dana-Farber Cancer Care Collaborative,” explains oncologist Rodrigo Maegawa, MD, medical director, EMMC Cancer Care. “Often a clinical trial is the best option for patients. With breast cancer being one of the most prevalent kinds of cancer in Maine, we may be able to provide the most effective choice through this trial for patients who meet the criteria.”
The PELOPS protocol, named for Palbociclib and Endocrine Therapy for Lobular Breast Cancer Preoperative Study, is a randomized clinical trial that combines the use of endocrine therapy with or without the oral medication Palbociclib for patients who have not had tumor removal surgery, have early stage lobular breast cancer, are estrogen and/or progesterone positive, and HER2 negative with a minimum tumor size of1.5 cm.
Trials such as these build on Eastern Maine Medical Center’s long standing relationship with the leading cancer research center, spanning more than four decades and extending oncology expertise to more Maine patients.
“Giving our patients access to clinical trials they would otherwise need to travel to Boston to participate in provides peace of mind without taking precious time away from work and family,” says Dr. Maegawa. “This summer, we look forward to offering more local options for patients by opening new trials through the Dana-Farber Cancer Care Collaborative.”
Eastern Maine Medical Center is one of four sites in the nation that offer cancer trials, such as PELOPS, because of collaboration with Dana-Farber Cancer Institute. EMMC Cancer Care is currently part of 44 adult oncology clinical trials, made possible through various research organizations throughout the US.
To learn more about cancer treatments available, visit cancer.emmc.org.